000518 四环生物
交易中 09-07 13:14:15
资讯
新帖
简况
四环生物：公司将于2026年9月21日召开2026年第二次临时股东会
证券日报网 · 09-04 21:22
四环生物：公司将于2026年9月21日召开2026年第二次临时股东会
四环生物最新公告：拟1.6亿元收购中润药业65.61%股权
证券之星 · 09-04 18:49
四环生物最新公告：拟1.6亿元收购中润药业65.61%股权
四环生物：截至2026年8月20日，公司股东人数为67353
证券之星 · 08-27
四环生物：截至2026年8月20日，公司股东人数为67353
股市必读：四环生物中报 - 第二季度单季净利润同比下降349.66%
证券之星 · 08-24
股市必读：四环生物中报 - 第二季度单季净利润同比下降349.66%
四环生物（000518）2026年中报简析：净利润同比下降155.8%
证券之星 · 08-22
四环生物（000518）2026年中报简析：净利润同比下降155.8%
四环生物(000518)8月10日股东户数6.53万户，较上期增加1.85%
证券之星 · 08-21
四环生物(000518)8月10日股东户数6.53万户，较上期增加1.85%
图解四环生物中报：第二季度单季净利润同比下降349.66%
证券之星 · 08-21
图解四环生物中报：第二季度单季净利润同比下降349.66%
四环生物（000518）披露2026年半年度报告，8月20日股价上涨0.27%
证券之星 · 08-20
四环生物（000518）披露2026年半年度报告，8月20日股价上涨0.27%
股市必读：四环生物新发布《江苏四环生物股份有限公司第十一届董事会第二次会议决议公告》
证券之星 · 08-19
股市必读：四环生物新发布《江苏四环生物股份有限公司第十一届董事会第二次会议决议公告》
股市必读：四环生物新发布《江苏四环生物股份有限公司第十一届董事会第二次会议决议公告》
证券之星 · 08-18
股市必读：四环生物新发布《江苏四环生物股份有限公司第十一届董事会第二次会议决议公告》
四环生物（000518）披露签订股权转让意向协议公告，8月17日股价上涨1.25%
证券之星 · 08-17
四环生物（000518）披露签订股权转让意向协议公告，8月17日股价上涨1.25%
四环生物最新公告：拟1.6亿元收购长源药业80%股权
证券之星 · 08-17
四环生物最新公告：拟1.6亿元收购长源药业80%股权
四环生物：截至2026年7月20日，公司股东人数为65060
证券之星 · 07-30
四环生物：截至2026年7月20日，公司股东人数为65060
四环生物（000518）披露2026年半年度业绩预告，7月13日股价下跌5.66%
证券之星 · 07-13
四环生物（000518）披露2026年半年度业绩预告，7月13日股价下跌5.66%
四环生物：预计2026年1-6月每股收益亏损:0.0204元至0.0291元
证券之星 · 07-10
四环生物：预计2026年1-6月每股收益亏损:0.0204元至0.0291元
四环生物（000518）披露控股股东上层股权结构变动暨完成工商变更登记的公告，6月30日股价上涨1.57%
证券之星 · 06-30
四环生物（000518）披露控股股东上层股权结构变动暨完成工商变更登记的公告，6月30日股价上涨1.57%
四环生物（000518）披露2026年第一次临时股东会决议公告，6月25日股价下跌1.8%
证券之星 · 06-25
四环生物（000518）披露2026年第一次临时股东会决议公告，6月25日股价下跌1.8%
股市必读：四环生物（000518）6月16日董秘有最新回复
证券之星 · 06-17
股市必读：四环生物（000518）6月16日董秘有最新回复
四环生物：截至2026年6月10日，公司股东人数为81375
证券之星 · 06-16
四环生物：截至2026年6月10日，公司股东人数为81375
四环生物：截至2026年5月31日，公司股东人数为88410
证券之星 · 06-09
四环生物：截至2026年5月31日，公司股东人数为88410
加载更多
公司概况
公司名称：
江苏四环生物股份有限公司
所属行业：
医药制造业
上市日期：
1993-09-08
主营业务：
江苏四环生物股份有限公司的主营业务是生物医药制品的生产和销售；苗木的种植、销售及绿化工程业务。公司的主要产品是生物药品、处方药。
发行价格：
2.50
{"stockData":{"symbol":"000518","market":"SZ","secType":"STK","nameCN":"四环生物","latestPrice":3.85,"timestamp":1788758055000,"preClose":3.9,"halted":0,"volume":32847400,"delay":0,"changeRate":-0.0128,"floatShares":1030000000,"shares":1030000000,"eps":-0.0514,"marketStatus":"交易中","change":-0.05,"latestTime":"09-07 13:14:15","open":3.9,"high":3.99,"low":3.83,"amount":128000000,"amplitude":0.041,"askPrice":3.85,"askSize":685,"bidPrice":3.84,"bidSize":1216,"shortable":0,"etf":0,"ttmEps":-0.0514,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1788764400000},"marketStatusCode":2,"adr":0,"adjPreClose":3.9,"symbolType":"stock","openAndCloseTimeList":[[1788744600000,1788751800000],[1788757200000,1788764400000]],"highLimit":4.29,"lowLimit":3.51,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":1029556222,"isCdr":false,"pbRate":13,"roa":"--","roe":"--","epsLYR":-0.036,"committee":0.906042,"marketValue":3964000000,"turnoverRate":0.0319,"status":1,"floatMarketCap":3964000000},"requestUrl":"/m/hq/s/000518","defaultTab":"news","newsList":[{"id":"2664370263","title":"四环生物：公司将于2026年9月21日召开2026年第二次临时股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2664370263","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664370263?lang=zh_cn&edition=full","pubTime":"2026-09-04 21:22","pubTimestamp":1788528120,"startTime":"0","endTime":"0","summary":"证券日报网讯9月4日，四环生物（维权）发布公告称，公司将于2026年9月21日召开2026年第二次临时股东会。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-04/doc-iniqsran0812294.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-04/doc-iniqsran0812294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000518","BK0046","BK0168","BK0145","BK0239","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664104336","title":"四环生物最新公告：拟1.6亿元收购中润药业65.61%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2664104336","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664104336?lang=zh_cn&edition=full","pubTime":"2026-09-04 18:49","pubTimestamp":1788518983,"startTime":"0","endTime":"0","summary":"四环生物(000518.SZ)公告称，公司拟以现金1.6亿元收购中润药业65.6146%股权，交易完成后中润药业将成为控股子公司。同时，中润药业将向定向减资方定向减少17.9817%股权，不支付减资对价，减资完成后公司将持有其80%股权。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400035418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","000518","BK0239","BK0086","BK0046","BK0145"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662700693","title":"四环生物：截至2026年8月20日，公司股东人数为67353","url":"https://stock-news.laohu8.com/highlight/detail?id=2662700693","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662700693?lang=zh_cn&edition=full","pubTime":"2026-08-27 20:51","pubTimestamp":1787835087,"startTime":"0","endTime":"0","summary":"证券之星消息，四环生物(000518)08月26日在投资者关系平台上答复投资者关心的问题。投资者提问：请问8月20日股东人数是多少？谢谢四环生物回复：投资者您好，截至2026年8月20日，公司股东人数为67353。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700051293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0046","000518","BK0145","BK0086","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661061243","title":"股市必读：四环生物中报 - 第二季度单季净利润同比下降349.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661061243","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661061243?lang=zh_cn&edition=full","pubTime":"2026-08-24 01:25","pubTimestamp":1787505912,"startTime":"0","endTime":"0","summary":"业绩披露要点：2026年第二季度单季度归母净利润为-1451.94万元，同比下降349.66%。业绩披露要点财务报告2026年中报显示，上半年度公司主营收入1.11亿元，同比下降39.12%；归母净利润-2583.32万元，同比下降155.8%；扣非净利润-2817.44万元，同比下降135.59%；其中2026年第二季度单季度主营收入2957.22万元，同比下降78.58%；单季度归母净利润-1451.94万元，同比下降349.66%；单季度扣非净利润-1446.16万元，同比下降318.89%；负债率28.0%，投资收益0.0万元，财务费用49.65万元，毛利率20.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400000891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661388218","title":"四环生物（000518）2026年中报简析：净利润同比下降155.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661388218","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661388218?lang=zh_cn&edition=full","pubTime":"2026-08-22 06:08","pubTimestamp":1787350082,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期四环生物发布2026年中报。根据财报显示，四环生物净利润同比下降155.8%。截至本报告期末，公司营业总收入1.11亿元，同比下降39.12%，归母净利润-2583.32万元，同比下降155.8%。按单季度数据看，第二季度营业总收入2957.22万元，同比下降78.58%，第二季度归母净利润-1451.94万元，同比下降349.66%。投资活动产生的现金流量净额变动幅度为-310.85%,原因:报告期因处置子公司收到的现金同比减少。本文数据来源于四环生物2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082200004902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661269416","title":"四环生物(000518)8月10日股东户数6.53万户，较上期增加1.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661269416","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661269416?lang=zh_cn&edition=full","pubTime":"2026-08-21 17:40","pubTimestamp":1787305247,"startTime":"0","endTime":"0","summary":"证券之星消息，近日四环生物披露，截至2026年8月10日公司股东户数为6.53万户，较7月31日增加1186.0户，增幅为1.85%。在生物制品行业个股中，四环生物股东户数高于行业平均水平，截至8月10日，生物制品行业平均股东户数为3.53万户。从股价来看，2026年7月31日至2026年8月10日，四环生物区间涨幅为14.4%，在此期间股东户数增加1186.0户，增幅为1.85%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100032364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0239","BK0145","BK0046","000518","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661393772","title":"图解四环生物中报：第二季度单季净利润同比下降349.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661393772","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661393772?lang=zh_cn&edition=full","pubTime":"2026-08-21 01:23","pubTimestamp":1787246601,"startTime":"0","endTime":"0","summary":"证券之星消息，四环生物2026年中报显示，上半年度公司主营收入1.11亿元，同比下降39.12%；归母净利润-2583.32万元，同比下降155.8%；扣非净利润-2817.44万元，同比下降135.59%；其中2026年第二季度，公司单季度主营收入2957.22万元，同比下降78.58%；单季度归母净利润-1451.94万元，同比下降349.66%；单季度扣非净利润-1446.16万元，同比下降318.89%；负债率28.0%，投资收益0.0万元，财务费用49.65万元，毛利率20.57%。财报数据概要请见下图:本文数据来源于四环生物2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100001168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660383612","title":"四环生物（000518）披露2026年半年度报告，8月20日股价上涨0.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660383612","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660383612?lang=zh_cn&edition=full","pubTime":"2026-08-20 22:19","pubTimestamp":1787235554,"startTime":"0","endTime":"0","summary":"近日，江苏四环生物股份有限公司披露2026年半年度报告摘要显示，本报告期营业收入为110,742,539.50元，较上年同期的181,897,153.17元下降39.12%；归属于上市公司股东的净利润为-25,833,217.42元，较上年同期的-10,098,947.40元下降155.80%；扣除非经常性损益后的净利润为-28,174,380.60元，同比下降135.59%。本报告期末总资产为459,607,382.97元，较上年度末的494,042,669.78元下降6.97%；归属于上市公司股东的净资产为308,787,797.89元，较上年度末减少7.72%。公司控股股东和实际控制人在报告期内未发生变更。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000045341.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0145","000518","BK0086","BK0046","BK0239","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660995694","title":"股市必读：四环生物新发布《江苏四环生物股份有限公司第十一届董事会第二次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660995694","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660995694?lang=zh_cn&edition=full","pubTime":"2026-08-19 01:10","pubTimestamp":1787073018,"startTime":"0","endTime":"0","summary":"公司公告汇总江苏四环生物股份有限公司第十一届董事会第二次会议决议公告江苏四环生物股份有限公司于2026年8月17日召开第十一届董事会第二次会议，审议通过公司拟与江西济鑫生物科技有限公司签订《股权转让意向协议》，以现金方式收购其持有的吉林省长源药业有限公司80%股权，暂定转让价格为1.6亿元人民币。本次交易不构成关联交易，预计不构成重大资产重组。公司已召开董事会审议通过签订意向协议的议案，并授权管理层推进相关工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900001243.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000518","BK0168","BK0239","BK0145","BK0046","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660439051","title":"股市必读：四环生物新发布《江苏四环生物股份有限公司第十一届董事会第二次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660439051","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660439051?lang=zh_cn&edition=full","pubTime":"2026-08-18 01:01","pubTimestamp":1786986074,"startTime":"0","endTime":"0","summary":"公司公告汇总江苏四环生物股份有限公司第十一届董事会第二次会议决议公告江苏四环生物股份有限公司于2026年8月17日召开第十一届董事会第二次会议，审议通过公司拟与江西济鑫生物科技有限公司签订《股权转让意向协议》，以现金方式收购其持有的吉林省长源药业有限公司80%股权，暂定转让价格为1.6亿元人民币。本次交易不构成关联交易，预计不构成重大资产重组。公司已召开董事会审议通过签订意向协议的议案，并授权管理层推进相关工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800001356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0239","000518","BK0086","BK0145","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660743586","title":"四环生物（000518）披露签订股权转让意向协议公告，8月17日股价上涨1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660743586","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660743586?lang=zh_cn&edition=full","pubTime":"2026-08-17 22:14","pubTimestamp":1786976080,"startTime":"0","endTime":"0","summary":"截至2026年8月17日收盘，四环生物报收于4.06元，较前一交易日上涨1.25%，最新总市值为41.8亿元。该股当日开盘4.01元，最高4.16元，最低3.92元，成交额达2.26亿元，换手率为5.45%。近日，江苏四环生物股份有限公司发布《关于签订股权转让意向协议的公告》。公告显示，公司拟以现金方式收购吉林省长源药业有限公司80%的股权，暂定转让价格为1.6亿元人民币。公司已召开董事会审议通过签订意向协议的议案，并授权管理层推进相关工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700035193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000518","BK0239","BK0046","BK0145","BK0168","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660484671","title":"四环生物最新公告：拟1.6亿元收购长源药业80%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2660484671","media":"证券之星","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660484671?lang=zh_cn&edition=full","pubTime":"2026-08-17 19:00","pubTimestamp":1786964426,"startTime":"0","endTime":"0","summary":"四环生物(000518.SZ)公告称，公司拟以现金方式收购吉林长源药业80%股权，交易对价1.6亿元。标的公司主营药品生产销售，核心产品为琥珀酰明胶注射液。本次交易尚处筹划阶段，最终能否达成存在不确定性。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700027745.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0046","BK0168","BK0239","000518","BK0145"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655870951","title":"四环生物：截至2026年7月20日，公司股东人数为65060","url":"https://stock-news.laohu8.com/highlight/detail?id=2655870951","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655870951?lang=zh_cn&edition=full","pubTime":"2026-07-30 20:51","pubTimestamp":1785415874,"startTime":"0","endTime":"0","summary":"证券之星消息，四环生物(000518)07月29日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止7月20日公司股东数？四环生物回复：投资者您好，截至2026年7月20日，公司股东人数为65060。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073000037323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0145","BK0168","BK0086","BK0239","000518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651266190","title":"四环生物（000518）披露2026年半年度业绩预告，7月13日股价下跌5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651266190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651266190?lang=zh_cn&edition=full","pubTime":"2026-07-13 17:46","pubTimestamp":1783936008,"startTime":"0","endTime":"0","summary":"截至2026年7月13日收盘，四环生物报收于3.83元，较前一交易日下跌5.66%，最新总市值为39.43亿元。该股当日开盘4.01元，最高4.05元，最低3.8元，成交额达3.96亿元，换手率为9.9%。近日，公司披露《江苏四环生物股份有限公司2026年半年度业绩预告》。业绩亏损主要因控股子公司北京四环生物制药有限公司受药品集中带量采购政策影响，主要产品售价下滑，营业收入下降，亏损增加。本次业绩预告未经审计，最终数据以2026年半年度报告为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300026597.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0239","BK0168","000518","BK0046","BK0145"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650187299","title":"四环生物：预计2026年1-6月每股收益亏损:0.0204元至0.0291元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650187299","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650187299?lang=zh_cn&edition=full","pubTime":"2026-07-10 20:01","pubTimestamp":1783684918,"startTime":"0","endTime":"0","summary":"证券之星消息，四环生物发布业绩预告，预计2026年1-6月每股收益亏损:0.0204元至0.0291元。四环生物2026年一季报显示，一季度公司主营收入8117.03万元，同比上升85.14%；归母净利润-1131.38万元，同比上升28.91%；扣非净利润-1371.28万元，同比上升26.14%；负债率27.57%，投资收益0.0万元，财务费用42.78万元，毛利率19.13%。本文数据来源于《四环生物:江苏四环生物股份有限公司2026年半年度业绩预告》，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000039797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0145","BK0086","BK0168","BK0046","000518","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647529585","title":"四环生物（000518）披露控股股东上层股权结构变动暨完成工商变更登记的公告，6月30日股价上涨1.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647529585","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647529585?lang=zh_cn&edition=full","pubTime":"2026-06-30 22:26","pubTimestamp":1782829582,"startTime":"0","endTime":"0","summary":"近日，江苏四环生物股份有限公司发布《关于控股股东上层股权结构变动暨完成工商变更登记的公告》。本次变动完成后，邱为碧持有温度投资95.5%股权，朝舜投资不再持有股权。相关工商变更登记已办理完成。公告指出，本次变动未导致公司控股股东和实际控制人发生变化，公司控股股东仍为碧水投资，实际控制人仍为邱为碧；本次变动不涉及公司层面的增持或减持，不涉及要约收购，对公司日常经营无实质影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000047177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0145","BK0239","BK0086","BK0168","BK0046","000518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646809048","title":"四环生物（000518）披露2026年第一次临时股东会决议公告，6月25日股价下跌1.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646809048","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646809048?lang=zh_cn&edition=full","pubTime":"2026-06-25 22:44","pubTimestamp":1782398660,"startTime":"0","endTime":"0","summary":"截至2026年6月25日收盘，四环生物报收于3.28元，较前一交易日下跌1.8%，最新总市值为33.77亿元。该股当日开盘3.3元，最高3.35元，最低3.16元，成交额达1.49亿元，换手率为4.46%。近日，江苏四环生物股份有限公司发布《2026年第一次临时股东会决议公告》。公告显示，公司于2026年6月25日召开2026年第一次临时股东会，审议通过选举第十一届董事会成员及修订董事、高管薪酬管理制度的议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500044504.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0046","BK0145","BK0239","000518","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644762530","title":"股市必读：四环生物（000518）6月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2644762530","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644762530?lang=zh_cn&edition=full","pubTime":"2026-06-17 02:39","pubTimestamp":1781635150,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，四环生物报收于3.21元，上涨0.94%，换手率3.58%，成交量36.81万手，成交额1.17亿元。投资者： 请问截止6月 15日公司股东数？董秘： 投资者您好，截至2026年6月10日，公司股东人数为81375。交易信息汇总资金流向6月16日主力资金净流出846.41万元，占总成交额0.0%；游资资金净流出74.85万元，占总成交额0.0%；散户资金净流入921.26万元，占总成交额0.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700001045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0145","000518","BK0168","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643158757","title":"四环生物：截至2026年6月10日，公司股东人数为81375","url":"https://stock-news.laohu8.com/highlight/detail?id=2643158757","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643158757?lang=zh_cn&edition=full","pubTime":"2026-06-16 20:52","pubTimestamp":1781614373,"startTime":"0","endTime":"0","summary":"证券之星消息，四环生物(000518)06月16日在投资者关系平台上答复投资者关心的问题。投资者提问：请问6月12号股东数四环生物回复：投资者您好，截至2026年6月10日，公司股东人数为81375。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600042079.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0239","000518","BK0086","BK0145","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642460494","title":"四环生物：截至2026年5月31日，公司股东人数为88410","url":"https://stock-news.laohu8.com/highlight/detail?id=2642460494","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2642460494?lang=zh_cn&edition=full","pubTime":"2026-06-09 20:53","pubTimestamp":1781009601,"startTime":"0","endTime":"0","summary":"证券之星消息，四环生物(000518)06月09日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止5月29日股东数？谢谢四环生物回复：投资者您好，截至2026年5月31日，公司股东人数为88410。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900036681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0145","BK0239","BK0086","BK0168","000518","BK0046"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1788758059014,"stockEarnings":[{"period":"1week","weight":0.0052},{"period":"1month","weight":0.0026},{"period":"3month","weight":0.1143},{"period":"6month","weight":0.3879},{"period":"1year","weight":0.6456},{"period":"ytd","weight":0.6183}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0133},{"period":"3month","weight":-0.0242},{"period":"6month","weight":-0.0471},{"period":"1year","weight":0.0436},{"period":"ytd","weight":-0.0098}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏四环生物股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"67353人(较上一季度增加3.08%)","perCapita":"15285股","listingDate":"1993-09-08","address":"江苏省无锡市江阴市滨江东路2号41楼05、06座","registeredCapital":"102955万元","survey":" 江苏四环生物股份有限公司的主营业务是生物医药制品的生产和销售；苗木的种植、销售及绿化工程业务。公司的主要产品是生物药品、处方药。","listedPrice":2.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"四环生物(000518)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供四环生物(000518)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"四环生物,000518,四环生物股票,四环生物股票老虎,四环生物股票老虎国际,四环生物行情,四环生物股票行情,四环生物股价,四环生物股市,四环生物股票价格,四环生物股票交易,四环生物股票购买,四环生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"四环生物(000518)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供四环生物(000518)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}